REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bercham Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Bercham Pharma Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Bercham Pharma Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Ipoh. The enterprise currently operates in the Pharmacies and Drug Stores sector. Bercham Pharma Sdn. Bhd. was incorporated on April 27, 2017. There was a net sales revenue drop of 6.15% reported in Bercham Pharma Sdn. Bhd.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 6.51%. In 2024, Bercham Pharma Sdn. Bhd.’s net profit margin increased by 0.62%.

Headquarters
No. 44, Persiaran Bercham Selatan 1, Taman Desa Kenchana
Ipoh; Perak; Postal Code: 31400

Contact Details: Purchase the Bercham Pharma Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Bercham Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
April 27, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Subsidiaries
Htm Pharmacy (Pusing) Sdn. Bhd.
51%
Company Performance
Financial values in the chart are available after Bercham Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-6.15%▼
Total operating revenue
-6.15%▼
Operating Profit/Loss (EBIT)
9.37%▲
EBITDA
-16.17%▼
Net Profit/Loss for the Period
7.59%▲
Total Assets
6.51%▲
Total Equity
18.18%▲
Operating Profit Margin (ROS)
0.83%▲
Net Profit Margin
0.62%▲
Return on Equity (ROE)
-1.75%▼
Quick Ratio
1.33%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo